GABRIELLE HUNTER: Open Payments
NPI 1366228249 · ROCHESTER HILLS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$521 in 27 payments from 13 companies in 2025. Trend: 2023 $71 · 2024 $311 · 2025 $521
Food & beverage: $521
| Company | Payments | Amount |
|---|---|---|
| Corium, LLC | 11 | $104 |
| Janssen Pharmaceuticals, Inc | 1 | $87 |
| Supernus Pharmaceuticals, Inc. | 3 | $62 |
| Vanda Pharmaceuticals Inc. | 2 | $56 |
| ABBVIE INC. | 2 | $34 |
| HARMONY BIOSCIENCES LLC | 1 | $29 |
| Tris Pharma Inc | 1 | $27 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $24 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
| Noven Therapeutics, LLC | 1 | $21 |
Products named: Azstarys, SPRAVATO, Qelbree, FANAPT, REXULTI, VRAYLAR, WAKIX, Dyanavel XR.
Industry payments across MI — which companies pay providers there.
